科伦药业(002422.SZ)：公司药品纳入国家医保目录

Core Viewpoint - Sichuan Kelun Pharmaceutical Co., Ltd. and its subsidiaries have five products included in the National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug List for 2025, which is expected to enhance market expansion and sales scale for the company [1] Group 1 - The National Healthcare Security Administration and the Ministry of Human Resources and Social Security issued a notice regarding the inclusion of specific drugs in the 2025 drug list [1] - The inclusion of these products is anticipated to positively impact the company's market network and sales, although the exact effect on operating performance is currently unquantifiable [1] - The 2025 drug list will be officially implemented on January 1, 2026, with further details on reimbursement standards and policies to be announced by relevant government departments [1]